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Abstract
Chronic traumatic encephalopathy (CTE) is a form of neurodegeneration that results from repetitive brain trauma.
Not surprisingly, CTE has been linked to participation in contact sports such as boxing, hockey and American
football. In American football getting “dinged” equates to moments of dizziness, confusion, or grogginess that can
follow a blow to the head. There are approximately 100,000 to 300,000 concussive episodes occurring in the game
of American football alone each year. It is believed that repetitive brain trauma, with or possibly without
symptomatic concussion, sets off a cascade of events that result in neurodegenerative changes highlighted by
accumulations of hyperphosphorylated tau and neuronal TAR DNA-binding protein-43 (TDP-43). Symptoms of CTE
may begin years or decades later and include a progressive decline of memory, as well as depression, poor
impulse control, suicidal behavior, and, eventually, dementia similar to Alzheimer’s disease. In some individuals, CTE
is also associated with motor neuron disease similar to amyotrophic lateral sclerosis. Given the millions of athletes
participating in contact sports that involve repetitive brain trauma, CTE represents an important public health issue.
In this review, we discuss recent advances in understanding the etiology of CTE. It is now known that those
instances of mild concussion or “dings” that we may have previously not noticed could very well be causing
progressive neurodegenerative damage to a player’s brain. In the future, focused and intensive study of the risk
factors could potentially uncover methods to prevent and treat this disease.
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Introduction
Chronic traumatic encephalopathy (CTE) is a neurode-
generative disease that is believed to result from repeti-
tive brain trauma. Not surprisingly, CTE has been
linked to participation in popular contact sports such as
boxing, American football, wrestling, and soccer. Char-
acterized by a progressive taupathy and also marked by
TAR DNA-binding protein-43 (TDP-43) proteinopathy,
CTE has only been found in individuals with a history
of repeated brain trauma (Gavett et al. 2011; McKee et
al. 2009; McKee et al. 2010; Stern et al. 2011). Risk of
brain trauma ranges from asymptomatic subconcussive
blows to symptomatic concussion to more moderate or
severe forms of traumatic brain injury (TBI). Originally
termed “dementia pugilistica” because of its association
with boxing, the neuropathology of CTE was first
described by Corsellis in 1973 in a case series of 15
retired boxers (Corsellis et al. 1973). CTE results in a
progressive decline of memory and cognition, as well as
depression, suicidal behavior, poor impulse control,
aggressiveness, and eventually dementia similar to Alz-
heimer’s disease (AD). In some individuals CTE is asso-
ciated with motor neuron disease, which appears
clinically similar to amyotrophic lateral sclerosis (ALS).
Given the millions of individuals, both young and old,
participating in contact sports that involve repetitive
brain trauma, as well as military personnel with repeated
episodes of explosive blast-induced mild TBI (Elder et
al. 2010), CTE represents an important public health
issue.
This article will discuss recent advances in under-
standing the incidence, clinical expression, neuropathol-
ogy (gross and microscopic), and management of CTE,
with particular emphasis on contact sports-related CTE
because it has been more consistently described in the
medical literature.
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Epidemiology
In the United States, approximately 75% of individuals
with TBI sustain a mild TBI also known as a concussion
(Centers for Disease Control and Prevention: Report to
Congress on mild traumatic brain injury in the United
States: steps to prevent a serious public health problem.
In. Atlanta (GA) 2003). According to the Consensus State-
ment on Concussion in Sport (McCrory et al. 2009), a
concussion is defined as “a complex pathophysiological
process affecting the brain, induced by traumatic biome-
chanical forces.” For example, a direct blow to the head or
elsewhere on the body with an impulsive force transmitted
to the head may result in a graded set of neurological
symptoms with or without loss of consciousness. Although
concussion may result in neuropathological changes, the
acute clinical symptoms largely result from cytoskeletal
and metabolic disturbances that are temporary. No
abnormality on standard structural neuroimaging studies
is seen in concussion Moreover, the majority of deficits
associated with a concussive injury are short-lived and
typically resolve spontaneously within a matter of days,
weeks, or months; however, it is important to note, that in
a small percentage of individuals (~15%), post-concussion
symptoms may be prolonged after the initial injury
(McCrory et al. 2009). Concussed individuals sometimes
experience the long-term effects of postconcussion syn-
drome, for months or even years, which can result in sig-
nificant physical and emotional stress.
Contact sports athletes are commonly exposed to con-
cussions. In 1928, Harrison Martland, a New Jersey
pathologist and medical examiner, described a series of
symptoms in boxers, which he termed “punch drunk,”
that appeared to result from the repeated blows to the
head experienced in the sport (Martland HS: Punch-
drunk. JAMA 1928). “Nearly one half of the fighters
who have stayed in the game long enough,” were
described to exhibit cognitive, behavioral, or motor
abnormalities that were well known to lay persons
within the boxing community and referred to as
“punch-drunk syndrome.” In 1937, the more formal
term dementia pugilistica was introduced (Millspaugh
1937), emphasizing the severity of cognitive dysfunction
in boxers. Boxers present with various symptoms indica-
tive of damage to the pyramidal and extrapyramidal sys-
tems which manifest most often as disturbed gait and
coordination, slurred speech, and tremors, as well as
cerebral dysfunction causing cognitive impairments and
neurobehavioral disturbances including suicide (Omalu
et al. 2010a). By 1973, dementia pugilistica was replaced
by the term CTE, a neuropathologically distinct disorder
due to repetitive head trauma not only in boxers
(McCrory et al. 2007) but also in other contact sports
(Corsellis et al. 1973).
Costanza and colleagues described the clinical pro-
gression of a former professional boxer who developed
CTE (Costanza et al. 2011). The patient started boxing
at 17 years of age and at 22 he was at the European
championship level. At the age of 24, he began to exhi-
bit bizarre behavior and from the age of 25, he devel-
oped a progressive symptomatology characterized by
extra-pyramidal hyperkinetic-rigid syndrome, pyramidal
signs, epilepsy, cognitive impairment, and psychiatric/
behavioral symptoms. Neuropathological analysis after
he died at the age of 58 of a pulmonary embolism
revealed large numbers of neurofibrillary tangles (NFTs)
concentrated in the supragranular layers of the neocor-
tex (Costanza et al. 2011). Interestingly, the distribution
of NFTs in neocortical association areas is unique to
CTE and not observed in typical AD cases. NFTs in
CTE were primarily located in superficial layers (II and
upper III), whereas in AD they predominate in deep
layers (V and VI), correlating with the location of neu-
rons forming specific corticocortical connections (Cost-
anza et al. 2011).
The frequency of CTE in professional boxers is esti-
mated to be 0.8 brain injuries per 10 rounds (Heilbron-
ner et al. 2009). Approximately 20% of retired
professional boxers developed CTE (Jordan 2000;
McCrory et al. 2007). Risk factors associated with CTE
include increased exposure (e.g., duration of career, age
of retirement, total number of bouts), poor performance,
and increased sparring (Jordan 2000; Jordon et al. 1997).
High-exposure boxers (12 or more professional bouts)
had significantly higher measures on the Chronic Brain
Injury (CBI) scale than low-exposure boxers, indicating
that neurologic impairment is related to boxing expo-
sure. Both amateur and professional boxers are poten-
tially at risk of developing CTE although whether
amateur boxing leads to chronic TBI has been disputed
(Loosemore et al. 2007; Porter 2003; Haglund& Eriksson
1993). In a small, controlled, prospective study of com-
petitive amateur boxers in Ireland, there was no evi-
dence of a decline in cognitive function over nine years
per raw scores and changes in score in several neurop-
sychological tests including the Trail Making Test Parts
A and B and Digit Symbol (Porter 2003). The Trail
Making Test is a test of visual attention and task switch-
ing. The Digit Symbol Test measures processing speed
requiring the subject to copy symbols that match the
numbers 1-9 according to a key. Both tests have been
validated for assessing dementia (Ashendorf et al. 2008;
Tierney et al. 2010).
Haglund and Eriksson (Haglund & Eriksson 1993)
found a higher incidence of slight or moderate electro-
encephalography deviations and inferior finger-tapping
performance among amateur boxers compared with two
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control groups of soccer players and track and field ath-
letes, but no significant differences between the groups
on computed tomography (CT) images or magnetic
resonance imaging (MRI). In addition, there were no
significant differences in the width of the ventricular
system, anterior horn index, width of cortical sulci, signs
of vermian atrophy, or the occurrence of a cavum sep-
tum pellucidum between Swedish amateur boxers and
controls in a retrospective study with CT and MRI
(Haglund & Bergstrand 1990).
Although initially seen in professional boxers, CTE has
now been identified in a number of athletes competing
in different contact sports including amateur and profes-
sional wrestling, professional hockey, professional soccer
and American football. Professional wrestling is a con-
tact sport with a high risk for players to sustain repeated
concussions over their careers. Omalu and colleagues
reported tissue substrates and forensic evidence for CTE
in a professional American wrestler (Omalu et al.
2010b). Histochemical analysis revealed diffuse, sparse
to frequent tau-immunoreactive NFTs in the neocortex,
subcortical ganglia, and brainstem nuclei. Recently,
Omalu and colleagues (Omalu et al. 2010c) presented a
case of CTE in a retired National Football League (NFL)
player. The brain tissue revealed diffuse cerebral taupa-
thy (NFTs and neuritic threads (NT)) without any neuri-
ticamyloidopathy. Omalu and colleagues reported the
first two cases of CTE in retired NFL players in 2005
(Omalu et al. 2005) and 2006 (Omalu et al. 2006). Both
patients’ medical history included symptoms of cognitive
impairment, a mood disorder, and parkinsonian symp-
toms after retirement. There was no family history of
AD or any other head trauma outside of football. In the
first case, a comprehensive neuropathological examina-
tion was performed approximately 12 years after retire-
ment. On autopsy, the brain demonstrated no cortical
atrophy, cortical contusion, or infarcts. There was mild
neuronal cell loss in the frontal, parietal, and temporal
neocortex. CTE was evident by the demonstration of
NFTs or neuropil threads in the hippocampus or
entorhinal cortex. (Omalu et al. 2005).
The second reported case of autopsy-confirmed CTE
in a retired professional football player displayed neuro-
pathological features that differed from those of the first
reported case (Omalu et al. 2006). Relevant history
included a 14-year span of play in organized football
starting at the age of 18 years. The former athlete was
diagnosed with major depressive disorder without psy-
chotic features after retirement and after several failed
attempts, committed suicide. Both cases of CTE exhib-
ited tau positive NFTs and neuropil threads in the
brain; however, amyloid plaques were completely absent
in the second case (Omalu et al. 2005; Omalu et al.
2006). Reasons for the contrasting features in these two
cases are not clear. More recently, 14 of the 15 profes-
sional American football players examined neuropatho-
logically at the Veterans Affairs Center for the Study of
Traumatic Encephalopathy (CSTE) Brain Bank have
been diagnosed with CTE (Stern et al. 2011).
Cincinnati Bengals receiver Chris Henry (age 26) suf-
fered from CTE before he died tragically in December
2009. Co-directors of the Brain Injury Research Institute
at West Virginia, Julian Bailes, neurosurgeon, and Ben-
netOmalu, California medical examiner, made the stun-
ning announcement in early 2010 (Los Angeles Times
Staff and Wire Reports: Bengals’ Henry had chronic
brain injury. In: Los Angeles Times. Los Angeles 2010).
Henry was only 26 years old at the time of his death,
yet his brain already showed the pathophysiological
effects of CTE caused most likely by repetitive blows to
the brain.
Because repetitive closed head injuries seem to be the
cause of CTE, athletes involved in collision sports seem
to be at a high risk of developing the disorder. All con-
firmed cases of CTE have had a history of progressive
brain trauma. In American football, a “ding” is a concus-
sion or mild TBI caused by a blow to the head or body.
There are approximately 100,000 to 300,000 concussions
occurring in the game of football alone each year (Gus-
kiewicz et al. 2003). It is known that football players
and boxers experience thousands of subconcussive
blows during a career (Guskiewicz et al. 2003). Athletes
at certain positions (e.g., linemen) may sustain up to
1,400 impacts per season, and high school players who
play both offense and defense potentially sustain closer
to 2,000 impacts (McCrory et al. 2009; Herring et al.
2006; Talavage et al. 2010; Crisco et al. 2010; Greenwald
et al. 2008).
Recently, data based on direct measurements of head
impact exposure in college football players demon-
strated that running backs and quarterbacks suffer the
hardest and most severe blows to the head, while line-
men and linebackers suffer more head impacts during a
game than players in other positions (Crisco et al.
2011). Nearly 300,000 head impacts at three institutions
were recorded over three seasons. The researchers mea-
sured impacts with standard football helmets outfitted
with sensors that recorded such data as head accelera-
tion and impact location which allowed them to quan-
tify the severity and frequency of blows to the head by
player position. Offensive line and quarterbacks had the
highest and lowest frequency, respectively, of front
impacts. In contrast, quarterbacks received the greatest
magnitude and the most frequent impacts to the back of
the helmet. Data also suggest that top-of-head impacts
have a higher risk of concussion than impacts to the
front, right, or back of the head (Guskiewicz et al.
2007). Top-of-helmet impacts might result in causing
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the cerebellum to impact the base of the skull and recoil
superiorly into the cerebellar tentorium.
It is without question that NFL players are at a heigh-
tened risk for cognitive impairment and dementia (Gus-
kiewicz et al. 2005). In fact, since its inception in 2006,
the 88 Plan, jointly run by the NFL and the NFL Players
Association (NFLPA), has spent about $9.7 million
toward the care of 132 former NFL players with demen-
tia. The plan was named after former Baltimore Colts
tight end John Mackey who wore the #88 jersey.
Recently, the NFL and NFLPA expanded the 88 Plan to
include coverage of qualifying players for reimbursement
of expenses associated with ALS. Nevertheless, an ath-
lete in any sport who may have sustained more than
one concussive injury may be at a risk for CTE includ-
ing, but not limited to hockey, rugby, lacrosse, martial
arts, horseback riding, parachuting, and downhill skiing.
There is a rising incidence of TBI in hockey and body-
checking, thought by some to be a useful skill for win-
ning games, is a major risk for concussion in this sport
(Marchie&Cusimano MD: Bodychecking and concus-
sions in ice hockey: should our youth pay the price?
JAMC 2003). Concussions are rarely caused by being
struck with a puck (Honey 1998). In fact, the link
between bodychecking and concussions is analogous to
the association between smoking and lung cancer (Hill
1965). CTE has also been found in epileptics, physical
abuse victims, and a circus clown (McKee et al. 2009;
Gavett et al. 2011; Roberts et al. 1990). More worrisome
and less publicized are the increasing number of con-
cussions among younger, even little league baseball
players.
According to an analysis by the Centers for Disease
Control (CDC) and Prevention, emergency department
visits for sport-related TBI, including concussions,
among children and adolescents increased by 60% dur-
ing the last decade (2001 to 2009) (Prevention CfDCa:
Nonfatal traumatic brain injuries related to sports and
recreation activities among persons aged < 19 years-
United States 2001). The analysis in CDC’s Morbidity
and Mortality Weekly Report said that football, basket-
ball, bicycling, and soccer were the primary sports
involved. In Canada, 10-12% of minor league ice hockey
players 9-17 years old who are injured report a head
injury, most commonly a concussion (Cole 2003). A
review of the literature published between 1966 and
1997 revealed that youth aged 5-17 years-old experi-
enced approximately 2.8 concussions per 1000 player-
hours of ice hockey; the number per 1000 player-hours
was about the same among high school players (Honey
1998). Among Canadian amateur ice hockey players
over 18-years-old, the rate is 4.6-6.0 concussions per
1000 player-hours (Goodman et al. 2001). These num-
bers are alarming since the younger developing brain is
at an even higher risk of injury and repeated concus-
sions may lead to permanent learning disabilities and
other neurological and psychiatric problems. Pre-adoles-
cent youth with a TBI may never fully develop the social
and cognitive skills characteristic of adults and may be
more violent than those without such an injury (Leon-
Carrion & Ramose 2003; Benz et al. 1999). While the
most common cognitive sequelae of concussion in chil-
dren appear similar for children and adults, the recovery
profile and breadth of consequences in children remains
largely unknown, as does the influence of pre-injury
characteristics (e.g., gender) and injury details (e.g., mag-
nitude and direction of impact) on long-term outcomes.
Clinical presentation
Clinically, the diagnosis of CTE depends on the pre-
sence of progressively evolving neuropsychiatric symp-
toms attributable to repeated brain trauma that cannot
be attributed to other pathological processes. Unfortu-
nately, data on the clinical manifestations of CTE have
only recently been accumulating via post-mortem medi-
cal record review and interviews of friends or family
members of individuals with neuropathologically docu-
mented CTE.
The clinical symptoms of CTE are first evident by
deteriorations in attention, concentration and memory,
as well as disorientation and confusion, and occasionally
accompanied by dizziness and headaches. With progres-
sive deterioration, additional symptoms, such as poor
judgment, and overt dementia, become manifest. Severe
cases of CTE are accompanied by a progressive slowing
of muscular movements, a staggered and propulsive gait,
masked facies, impeded speech, tremors, vertigo, and
deafness (Millspaugh 1937). According to Corsellis et al.
(Corsellis et al. 1973) an individual with CTE may pro-
gress through three stages of the disease beginning with
affective disturbances and psychotic symptoms. As the
disease progresses to the second stage, the individual
may suffer from social instability, erratic behavior, mem-
ory loss, and the initial signs of Parkinson’s disease
(McKee et al. 2009). The third stage consists of a pro-
gressive deterioration to dementia, which is often
accompanied by speech and gait abnormalities, dysar-
thria, dysphagia, and ptosis (McKee et al. 2009). Of 51
neuropathologically confirmed cases of CTE of which
90% occurred in athletes (85% boxers, 11% football
players), the first symptoms of the disease were noticed
at age ranges from 25 to 76 years. One third were symp-
tomatic at the time of retirement from the sport and
half were symptomatic within 4 years of stopping play.
The severity of the disorder depends on which clinical
stage the individual is in (McKee et al. 2009) and
appears to correlate with the length of time engaged in
the sport and the number of traumatic injuries;
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however, where a single TBI can trigger the onset of
CTE remains a matter of speculation (McKee et al.
2009).
Mood and behavioral symptoms associated with CTE
are most concerning to family members and colleagues
and include depression, emotional instability, suicidal
thoughts, and problems with impulse control (Stern et
al. 2011). McKee et al. (McKee et al. 2009) recently
reviewed the clinical symptoms of CTE in 51 neuro-
pathologically confirmed cases of the disease in athletes.
In 30% of cases there was a prominent mood distur-
bance, usually depression (28%). Substance abuse and
suicide are common in CTE (Omalu et al. 2011)
(Omalu et al. 2010a; Omalu et al. 2010b; Omalu et al.
2010c). Omalu and colleagues (Omalu et al. 2010a)
recently presented five cases of professional American
contact sport athletes aged 36-50 years of age who com-
mitted suicide. While the brains appeared grossly nor-
mal at autopsy, immunohistochemical analysis revealed
widespread cerebral taupathy without neuritic plaques.
In a subsequent paper the authors (Omalu et al. 2011)
presented the case of CTE in a 27 year old US Marine
Corps Iraqi war veteran who was exposed to mortar
blasts and improvised explosive device blasts less than
50 meters away. Following his second deployment, he
developed a progressive history of cognitive impairment,
impaired memory, behavioral and mood disorders, and
alcohol abuse. He committed suicide approximately
eight months after his honorable discharge. His brain at
autopsy appeared grossly normal; however, immunohis-
tochemical analysis revealed CTE changes accentuated
in the depths of the frontal cortical sulci (Omalu et al.
2010a; Omalu et al. 2011). Cincinnati Bengals receiver
Chris Henry had suffered from CTE before he died at
the age of 26 years. Most recently, a brain autopsy of a
popular, 21-year-old defensive end on the University of
Pennsylvania football team who committed suicide
revealed that he suffered from CTE, the same repetitive
brain trauma-induced disease found in more than 20
deceased National Football League (NFL) players, two of
whom also committed suicide (Schwarz A: Suicide
reveals signs of a disease seen in N.F.L. In: The New
York Times. New York 2010). Thus, the brain damage
found in NFL veterans can afflict younger players who
may sustain thousands of subconcussive collisions while
the brain is developing. It is unclear if any of the neuro-
pathologic changes of CTE observed in the brain of
individuals in their teens are associated with behavioral
or cognitive symptoms at that time. (Omalu 2011).
Symptoms of CTE are consistent with those expected
from the neuropathological changes observed at autopsy.
For example, impairments in cognition are associated
with medial temporal and dorsolateral frontal degenera-
tion, changes in mood with amygdala degeneration, and
changes in behavior with amygdala and orbitofrontal
degeneration. Interestingly, a recent study showed that
overweight NFL players have significantly more
decreases in blood flow in the prefrontal cortex and
temporal pole, and greater cognitive impairment than
those retired NFL players categorized as normal weight
(Willeumier et al. 2012). Thus, it appears that both play-
ing professional American football and being overweight
result in additive risk factors for decreasing blood flow
and cognition. Although the disease process likely starts
at the time of injury, the initial signs of CTE do not
typically become evident until decades after the end of
exposure to repetitive brain injury. When symptoms of
CTE begin, the onset is earlier than that of sporadic AD
and usually earlier than that of frontotemporal dementia
(FTD).
Diagnostic features
The diagnosis of CTE relies on postmortem tissue ana-
lysis; therefore, forensic pathologists play an important
role in the identification and epidemiology of CTE since
the disease can only be definitively diagnosed by direct
tissue examination. Although the majority of profes-
sional and collegiate athletes examined for CTE have in
fact been found to have had the disease, this represents
a biased sample in that families who suspect their loved
ones may be impaired are more likely to agree to brain
donation for research purposes.
Gross pathology
Postmortem tissue analysis of athletes with a history of
repeated mild head injuries have produced several con-
sistent findings that, together, make CTE a distinctive
disorder. The gross neuropathologic changes of CTE,
which are typically observed in late-stage disease,
include generalized atrophy, most prominent in the
frontal and medial temporal lobes; enlargement of the
lateral and third ventricles; cavum septum pellucidum;
and usually septal fenestrations (see Figure 1) (Stern et
al. 2011). Additional gross changes include shrinkage of
the mammillary bodies, and atrophy of the hippocam-
pus, entorhinal cortex, and amygdala, which may result
in an overall reduction in brain size (Gavett et al. 2011;
McKee et al. 2009). Thinning of the hypothalamic floor
and pallor of the locus coeruleus and substantianigra
have also been noted (Gavett et al. 2011; McKee et al.
2009; Stern et al. 2011).
Microscopic neuropathology
Microscopically, CTE is characterized by a unique pattern
of extensive tau-immunoreactive NFTs primarily distribu-
ted in the frontal and temporal cortex (see Figure 2).
In advanced cases, tau-immunoreactive inclusions in the
limbic and paralimbic regions, diencephalon, brainstem,
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and subcortical white matter have also been reported
(Stern et al. 2011). The specific soluble and insoluble tau
isoforms that are found in the NFTs in CTE are indistin-
guishable from NFTs in AD (Schmidt et al. 2001) and the
ratio of tau isoforms with four versus three microtubule
binding repeats is approximately 1 in both diseases
(McKee et al. 2009). In the hippocampus and entorhinal
cortex, the NFT distribution is comparable to that
observed in AD, with numerous NFTs in the CA1 field,
subiculum and layer II and V of the entorhinal cortex
(Hof et al. 1992). However, b-amyloid deposition is an
inconstant feature in CTE, in contrast to the extensive b-
amyloid plaques that characterize nearly all cases of AD.
Approximately 50% of CTE patients lack significant b-
amyloid plaque accumulation (McKee et al. 2009). In addi-
tion, when b-amyloid deposits do occur they are less dense
Figure 1 Gross pathology of CTE. Top: Coronal section of a normal human brain. Bottom: Coronal section of a brain from a retired
professional football player, showing the characteristic gross pathology of CTE. Changes noted include severe dilatation of lateral ventricle (1)
and third ventricle (2), cavum septum pellucidum (3), marked atrophy of the medial temporal lobe structures (4), and shrinkage of the
mammillary bodies (5). Reprinted with permission from Stern et al. 2011 (Stern et al. 2011).
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than in AD (McKee et al. 2009). Moreover, the tau immu-
noreactive abnormalities in CTE tend to cluster at the
depths of sulci, around small blood vessels, and in superfi-
cial cortical layers (Gavett et al. 2011; McKee et al. 2009).
Thus, neuropathologically, the pattern of the
neurofibrillary abnormalities is distinct from AD especially
when considering the predominance of tau pathology over
b-amyloid accumulation in affected regions of the brain.
In addition to extensive tau-positive NFTs, the major-
ity of CTE cases are also marked by widespread TDP-43
Figure 2 Microscopic neuropathology of CTE. Top panel: Phosphorylated tau (AT8) immunostained coronal hemisections of a normal brain
(left) and a brain from a retired professional football player with CTE (right). The brain with CTE displays severe neurofibrillary degeneration of
the amygdala (a), entorhinal cortex (ec), temporal cortex, insular cortex (ins), nucleus basalis of Meynert (nbM), and frontal cortex. The cortical
changes are more pronounced at the depths of the sulci. Lower panels: (A) AT8-positive neurofibrillary tangles (NFTs) are often prominent at
the depths of the cortical sulci (original magnification: ×60). (B) Subpial AT-8- immunoreactive tangles are found in both neurons and astrocytes
(double-immunostained section for GFAP (red) and AT8 (brown), showing colocalization of tau and GFAP; ×350). (C) Dense AT8-NFTs are found
in the medial temporal lobe, including the CA1 region of the hippocampus, shown here. (×150). (D) AT-8-positive NFTs and astrocytic tangles
tend to be centered around small blood vessels and in subpial patches (×350). (E) NFTs characteristically involve cortical layers II and III (×150).
(F) NFT in a Betz cell of the primary motor cortex (×350). (G) Perivascular tau-immunoreactive NFTs in CTE (×150). Reprinted with permission
from Stern et al. 2011 (Stern et al. 2011).
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proteinopathy, that in some individuals is manifest as
motor neuron disease (McKee et al. 2010; King et al.
2010). TDP-43 is a 414 amino acid nuclear protein
encoded by the TARDBP gene on chromosome 1 (see
(Bigio 2008; Wang et al. 2008) for reviews). TDP-43 is a
highly conserved protein ubiquitously expressed in
many tissues including the CNS where it is present in
neuronal and glial nuclei and to a lesser extent in the
cytoplasm.
McKee and colleagues (McKee et al. 2010) examined
12 cases of CTE, and, in 10, found widespread TDP-43
immunoreactivity in the frontal and temporal cortex,
medial temporal lobe, basal ganglia, diencephalon, and
brainstem. The accumulation of TDP-43 as well as tau
in the neocortex, medial temporal lobes, and deeper
brain structures likely contributes to the overall clinical
manifestations of cognitive and memory loss, behavioral
changes, and parkinsonism (McKee et al. 2010). Three
athletes with CTE also developed a progressive motor
neuron disease that appears very similar to ALS (Brooks
et al. 2000) and is characterized by profound weakness,
atrophy, spasticity, and fasciculations several years
before death. In these 3 cases there were abundant
TDP-43-positive inclusions and neuritis in the spinal
cord in addition to tau NFTs, motor neuron loss, and
corticospinal tract degeneration (see Figure 3). Criteria
for diagnosis of ALS include evidence of both lower and
upper motor neuron degeneration and in terms of
neuropathology, degeneration of motor neurons with
ubiquitin-positive cytoplasmic inclusions and corticosp-
inal tract degeneration (Hirano 1996). In addition, in
sporadic ALS, remaining motor neurons often have ubi-
quitin-and TDP-43-immunoreactive inclusion bodies.
This is the first pathological evidence that repeated
brain trauma experienced in contact sports might be
associated with the development of a motor neuron dis-
ease and suggests that some forms of clinical ALS may
be associated with TBI.
Interestingly, TPD-43 inclusions are also found in
frontotemporal lobar degeneration (FTLD), which shares
a number of clinical and pathological features with ALS.
Originally, TDP-43 was thought to be specific to ALS
and FTLD, but it is now recognized to be present in a
variety of disorders (Geser et al. 2010), indicating that
these entities may share some pathogenic mechanisms
related to the pathological expression of this protein in
CTE. Although the physiological functions of TDP-43
are incompletely understood, by virtue of its capacity to
bind to neurofilament mRNA and stabilize the mRNA
transcript (Strong et al. 2007), TDP-43 plays a critical
role in mediating the response of the neuronal cytoske-
leton to axonal injury. Importantly, TPD-43 pathology
develops very early in the disease state and precedes
overt neurodegeneration by some as yet unspecified per-
iod of time. Other recent studies demonstrate the
absence of TDP-43 proteinopathy in acute and long-
Figure 3 Three cases of CTE with abundant TAR DNA-binding protein of approximately 43 kd (TDP-43) immunoreactivity and motor
neuron disease. (A-C) TDP-43 immunoreactive neurofibrillary degeneration in the frontal cortex of 3 cases of CTE + motor neuron disease (whole-
mount 50 μm sections immunostained for CP13, original magnification: ×1) (D-F) Tau-positive neurofibrillary tangles, glial tangles, and
neuropilneurites are particularly dense at the depth of the cortical sulci (×50). Adapted with permission from McKee et al. 2010 (McKee et al. 2010).
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term survivors of a single TBI in humans (Johnson et al.
2011). Multiple regions were examined including the
hippocampus, medial temporal lobe, cingulate gyrus,
superior frontal gyrus and brainstem. Thus, the absence
of TDP-43 proteinopathy may indicate a fundamental
difference in the processes following a single TBI from
those of repetitive TBI (Johnson et al. 2011).
Omalu recently reported (Omalu 2011) the case of
CTE in an 18 year old high school student who died
suddenly and unexpectedly following repeated concus-
sions while engaged in contact sports in school. Autopsy
revealed microscopic findings consistent with CTE.
What is very significant about this case is the evidence
of restricted tauopathy observed at such a young age.
The taupathy did not contribute to his sudden death;
however, it was diagnostic of incipient CTE, which the
authors concluded may have occurred had the individual
survived into his third- fifth decades of life (Omalu
2011).
The biological mechanisms by which repetitive brain
trauma may lead to CTE are not known. Recently, Blay-
lock and Maroon hypothesized that a process called
immunoexcitotoxicity may play a major role in the
development of progressive neurodegeneration in CTE
(Blaylock & Maroon 2011). According to the hypothesis,
chronic activation of microglia due to repetitive brain
trauma causes high levels of glutamate and a significant
accumulation of hyperphosphorylated tau protein result-
ing in the observed NFT accumulation in CTE. Compel-
ling research has linked excess glutamate stimulation
and/or elevations of proinflammatory cytokines to a
number of neuropsychiatric and behavioral conditions,
many of which are seen with CTE. Moreover, oxidative
stress induced by glutathione depletion reproduces
pathological modifications of TDP-43 linked to TDP-43
proteinopathies (Iguchi et al. 2011). More research is
needed to develop a set of criteria that provide a reliable
and valid indicator of neuropathologically verified CTE.
Examining the role of immunoexcitotoxicity and oxida-
tive stress in CTE may provide important early markers
of the disease and information on how to strengthen the
immune system to combat inflammation that could sig-
nificantly minimize brain damage.
Genetic risk and role of APOE ε4
Genetic disposition appears to be an important potential
risk factor for CTE and may one day explain why some
people develop CTE while most do not. One of the
genes thought to influence CTE risk is the apolipopro-
tein E (APOE = gene, apoE = protein) gene. As the
major lipoprotein involved in lipid transport and meta-
bolism (Mahley 1988), apoE expression is implicated in
neuronal growth and in repair after injury of both per-
ipheral and central neurons (Snipes et al. 1986; Ignatius
et al. 1986). There are three known isoforms of apoE,
coded for by the APOE ε2, APOE ε3, and APOE ε4
genes. Based on genetic testing conducted in conjunc-
tion with neuropathologic examinations of individuals
with a history of repeated head injuries, studies (Jordon
et al. 1997; Teasdale et al. 1997; Kutner et al. 2000)
have linked, specifically the APOE ε4 allele, to worse
cognitive functioning in boxers and professional Ameri-
can football players (Samatovicz 2000). In 10 cases of
CTE, 50% carried at least one APOE ε4 allele and 1 was
homozygous for APOE ε4 (McKee et al. 2009). In addi-
tion, all boxers with severe impairment as measured on
the CBI scale possessed at least one APOE ε4 allele (Jor-
don et al. 1997). When contrasted with the estimated
15% of the global population possessing at least one
APOE ε4 allele (Singh et al. 2006; Hill et al. 2007), the
frequency of this allele in those with CTE seems higher
than expected. Thus, the inheritance of an APOE ε4
allele might be a risk factor for the development of CTE.
Epidemiologic data have also implicated the APOE ε4
genotype as a risk factor for the development of AD
after TBI (Mayeux et al. 1995; Mayeux et al. 1993; Jor-
dan 2000; Jordon et al. 1997; Jordon 2007; McCrory
2007). Acute TBI induces Ab deposition in 30% of peo-
ple and a significant proportion of these individuals are
heterozygous for APOE ε4 (Nicoll et al. 1995). Carrying
the APOE ε4 allele is a risk factor for early onset AD
and is the only consistently identified risk factor for
late-onset AD. Carriers of two APOE ε4 alleles have a
higher risk and earlier onset of AD than heterozygous
subsets (Saunders et al. 1993). Recent genetic association
studies have explored the possible role of several other
gene polymorphisms in the neuropathological changes
of CTE; however, evidence for correlation with APOE
ε4 is the strongest.
Clinical diagnosis
The clinical diagnosis of CTE is difficult because pre-
sently there are no available biomarkers and no consen-
sus diagnostic criteria. In addition, its clinical
presentation can be similar to AD, FTD, sporadic ALS,
and other neurodegenerative diseases. Thus, the differ-
ential diagnosis of CTE often includes these diseases
especially in the later stages of the disorder. Older indi-
viduals with memory problems may seem to have AD,
and, in fact, may have evidence of AD and CTE neuro-
pathologically. When the age at onset is earlier and
accompanied by changes in behavior, it may be difficult
to rule out FTD (Gavett et al. 2011). Although a history
of repetitive head trauma is suggestive of CTE, head
trauma is also one of the strongest contenders for initi-
ating the molecular events that result in other neurode-
generative processes such as AD (Fleminger et al. 2003;
Plassman et al. 2000; Mortimer et al. 1985), FTD (Jawaid
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et al. 2009)and Parkinson disease (Goldman et al. 2006).
In addition, the etiology of sporadic ALS has long been
suspected to include a history of trauma to the brain
and spinal cord (Strickland et al. 1996; Chen et al.
2007), a history of participation in athletics (Scarmeas et
al. 2002), and strenuous physical activity (Scarmeas et al.
2002; Longstreth et al. 1998; Chiò et al. 2005; Belli
&Vanacore 2005). Thus, without neuropathologic con-
firmation, a diagnosis of CTE cannot be made with
confidence.
The overlap between CTE and AD involves not only
the similarities in the clinical expression of these disor-
ders but also their pathogenesis and epidemiology.
Pathologically, CTE shares several characteristics of AD
including abundant, widespread NFTs, acetylcholine
deficiency, and hyperphosphorylated tau (Hof et al.
1992; McKee et al. 2009). However, there are some
important differences. Clinically, CTE typically presents
with age of onset in the 40s and 50s as opposed to
onset after 65 years in sporadic AD. In addition, the
clinical progression of the disease is much slower, often
lasting decades, and is characterized by a subtle dete-
rioration in personality and behavior (Daneshvar et al.
2011). Neuropathologically, the pattern of the neurofi-
brillary abnormalities is distinct from AD especially
when considering the predominance of tau pathology
over b-amyloid accumulation in affected regions of the
brain.
From an epidemiological viewpoint, both positive and
negative data were reported in respect to the association
between a history of previous head trauma and risk of
AD. Meta-analyses supported a significant association
between head injury and AD, but only in men (Flemin-
ger et al. 2003; Mortimer et al. 1985; Gavett et al. 2010).
How brain injury can trigger the neurodegenerative
changes resulting in AD is still controversial. In addi-
tion, AD-like neurodegenerative changes following brain
injury may be present alone or in conjunction with
other types of neurodegenerative lesions.
The similarities between CTE and FTD focus on TDP-
43 proteinopathy. TDP-43 was recently established as the
major pathological protein in FTD with ubiquitin-posi-
tive and tau-negative inclusions, with or without motor
neuron disease/ALS, and in sporadic ALS, establishing
the concept of a spectrum of “TDP-43 proteinopathies.”
This protein is also widely present in CTE and in some
cases the TDP-43 proteinopathy involves the spinal cord
and may be associated with ALS (McKee et al. 2010).
In recent years research to investigate other neurode-
generative diseases, like AD, has been moving to inte-
grate clinical (e.g., neuropsychological tests), biological
(e.g., cerebrospinal fluid), anatomical (e.g., neuroima-
ging), and genetic information (e.g., APOE genotype) for
the purposes of differential diagnosis, prevention, and
treatment. This type of research approach is clearly
needed in order to arrive at the timely diagnosis of CTE.
Clinical guidelines for management
CTE is the only known neurodegenerative disease with a
specific identifiable cause; in this case, repetitive head
trauma, with or without symptomatic concussion.
Clearly, the easiest way to decrease the incidence of
CTE in athletes is to decrease the incidence of repetitive
brain trauma at all levels of play. Nevertheless, in the
US, approximately 1.7 million sports-and recreation-
related TBIs occur each year. About 75% of these cases
are classified as mild TBIs or concussions (Daneshvar et
al. 2011). In addition, players in collision sports such as
American football may experience many more subcon-
cussive impacts throughout a season and career.
Over the last 10 years, as part of the Heads Up initia-
tive (in Youth Sports & Activity 2007), the CDC has
worked to raise awareness about concussions, and
improve prevention, recognition, and response to this
injury among health care professionals, parents, coaches,
children and adolescents. Nevertheless, despite the
increased attention given to the frequent occurrence of
sports-related concussion, effective measures of preven-
tion of CTE in all levels of athletic involvement are still
lacking. Several early “return to play” (RTP) guidelines
for athletes who have sustained concussions have been
proposed including the Cantu guidelines (Cantu 1986),
the Colorado guidelines (Colorado Medical Society
1991), and the American Academy of Neurology guide-
lines for concussion management (American Academy
of Neurology 1997). Current RTP guidelines recommend
a graduated increase in the level of the activity of the
athlete progressing from the initial stage of “light exer-
cise” towards “full contact” activity once the athlete is
completely symptom-free at rest. The progression may
be complete in as little as five days or may take as long
as the athlete requires. According to Robert Stern, co-
director of CSTE, new evidence shows that 85% of con-
cussions require about three weeks of recovery (Abel D:
Bill addressing student concussions advances. In: Boston
Globe 2010). Studies using event-related potentials, tran-
scranial magnetic stimulation, balance testing, multitask
effect on gait stability, PET and diffusion tensor MRI
(DTI) have all shown abnormalities in concussed ath-
letes or non-athletes with TBI lasting for 2 to 4 weeks
(De Beaumont et al. 2007; Arfanakis et al. 2002; Gosse-
lin et al. 2006). Thus, safe RTP guidelines might require
at least 4 to 6 weeks to facilitate complete recovery and
to protect from re-injury, as a second concussion occurs
much more frequently in the immediate period after a
concussion (Guskiewicz et al. 2003; Mayers 2008).
Returning an athlete too early to sport after a concus-
sion may place the athlete at risk for second-impact
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syndrome, in which concussed cells may be irreversibly
damaged by the occurrence of swelling if a second con-
cussion is sustained (Signoretti et al. 2011). The largest
number of sudden deaths (57%) in young, competitive
athletes due to second-impact syndrome was in football
(Thomas et al. 2011). Stern offers his own recommenda-
tions specifically for the sport of football including redu-
cing full-contact practices, changing the way players line
up on the field, and using new helmets to reduce the
force of the impact on the football players’ brains (Abel
D: Bill addressing student concussions advances. In:
Boston Globe 2010). The best recommendations for the
prevention of CTE is to ensure that athletes who sustain
concussions be seen by sports medicine professionals
who have experience in treating concussions. Parents
need to also be educated as to the signs and symptoms
of concussion as they may be in the best situation to
detect subtle changes in their child’s behavior that
others may not notice.
The specific nature of the brain trauma exposure also
needs to be carefully studied. It is unknown whether
CTE is more likely to occur after extended exposure to
repetitive brain trauma or whether a single concussion
can initiate the neurodegenerative cascade in susceptible
individuals. In addition, all neuropathologically con-
firmed cases of CTE have had a history of repeated
head trauma; however, not all individuals with exposure
to brain trauma develop CTE. Thus, the contribution of
other variables, such as age, gender, and genetic predis-
position also require further investigation, as does the
role of oxidative stress in the disease process.
A major goal of research must be epidemiologic and
prospective studies to identify the specific risk factors for
the development of this neurodegenerative disease. Per
the CSTE, a large study is underway involving a number
of former NFL players to study their lives and then exam-
ine their brains following death. To this end, more than
500 living athletes have agreed to donate their brain and
spinal cord to the CSTE upon death, including over a
dozen former hockey players (Boston University
Researchers Report 2011). The VA CSTE Brain Donation
Registry allows for current and former athletes and mili-
tary personnel to pledge to donate their brain and spinal
cord to the CSTE (Brain Donation Registry).
Conclusion
CTE is a neuropathologically distinct neurodegenerative
disease that is believed to result from repetitive brain
trauma as frequently occurs in popular contact sports.
Early symptoms of CTE include a decline of memory
and cognitive functioning, depression, poor impulse
control and in many cases suicide. Disease progression
is slow and eventually leads to dementia. In some indivi-
duals CTE may also lead to a motor neuron disease
similar to ALS. What was once believed to occur only
in boxers is now openly discussed as a potential conse-
quence of repetitive brain trauma seen in multiple dif-
ferent sports and at all levels of play. Although we now
know that repetitive brain trauma sets off a cascade of
molecular events that results in neurodegeneration
marked by a unique taupathy and TDP-43 proteinopa-
thy, we do not know the underlying mechanism of the
disease. How can CBT be detected and diagnosed accu-
rately during life? How can CBT be prevented and trea-
ted? By addressing these important questions, CBT can
move from a disease only diagnosed postmortem to one
that can be identified, treated, and cured in life. In addi-
tion, new research will provide policy makers with
scientific data to make appropriate guidelines regarding
the treatment of brain trauma in athletes and military
personnel. Given the millions of athletes both young
and old participating in contact sports that involve repe-
titive brain trauma, CTE remains an important and
expanding health issue with unmet medical need.
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